000078.SZ
ST海王
SZSE · Healthcare · F 批发零售 · CN
CNY 1.59
−1.85%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 25.2B | 26.7B | 30.3B | 36.4B | 37.8B |
| Cost of Revenue | 22.9B | 24.2B | 27.4B | 32.9B | 34.0B |
| Gross Profit | 2.3B | 2.5B | 2.9B | 3.6B | 3.8B |
| Operating Expenses | |||||
| R&D Expense | 32.5M | 33.8M | 38.0M | 47.9M | 48.4M |
| SG&A Expense | — | — | — | — | — |
| General & Admin Expense | 853.0M | 881.6M | 1.1B | 1.1B | 1.2B |
| Selling & Marketing Expense | 880.7M | 926.1M | 1.2B | 1.4B | 1.5B |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 2.4B | 2.5B | 3.2B | 3.6B | 3.7B |
| Cost and Expenses | 25.3B | 26.7B | 30.6B | 36.5B | 37.8B |
| Operating Income (EBIT) | (548.5M) | (504.9M) | (1.1B) | (1.5B) | (854.6M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | — | — | — | — | — |
| Non-Operating Income (excl Interest) | — | — | — | — | — |
| EBT (Pre-Tax Income) | (544.0M) | (499.3M) | (1.1B) | (1.5B) | (853.2M) |
| Income Tax Expense | 36.5M | 53.3M | 85.6M | 260.6M | 138.3M |
| Bottom Line | |||||
| Net Income | (572.3M) | (563.1M) | (1.2B) | (1.7B) | (1.0B) |
| Earnings from Cont. Ops | (580.4M) | (552.6M) | (1.2B) | (1.7B) | (991.4M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (572.3M) | (563.1M) | (1.2B) | (1.7B) | (1.0B) |
| Per Share | |||||
| Basic EPS | (CN¥0.22) | (CN¥0.21) | (CN¥0.45) | (CN¥0.64) | (CN¥0.39) |
| Diluted EPS | (CN¥0.22) | (CN¥0.21) | (CN¥0.45) | (CN¥0.64) | (CN¥0.39) |
| Revenue Per Share | CN¥9.58 | CN¥10.14 | CN¥11.52 | CN¥13.84 | CN¥14.39 |
| Shares | |||||
| Basic Shares Outstanding | 2.6B | 2.6B | 2.6B | 2.6B | 2.6B |
| Diluted Shares Outstanding | 2.6B | 2.6B | 2.6B | 2.6B | 2.6B |
| Profitability Metrics | |||||
| EBITDA | — | (347.1M) | (875.0M) | (1.3B) | (657.8M) |
| D&A | — | 157.8M | 188.0M | 216.1M | 196.8M |
| EBIT | — | — | — | — | — |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026